Cargando…

Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia

An early detection and intervention for dementia represent tremendous unmet clinical needs and priorities in society. A shared feature of neurodegenerative diseases causing dementia is the abnormal accumulation and spreading of pathological protein aggregates, which affect the selective vulnerable c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Ruiqing, Nitsch, Roger M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761855/ https://www.ncbi.nlm.nih.gov/pubmed/35046791 http://dx.doi.org/10.3389/fnagi.2021.751897

Ejemplares similares

Genetic Algorithms for Optimized Diagnosis of Alzheimer’s Disease and Frontotemporal Dementia Using Fluorodeoxyglucose Positron Emission Tomography Imaging
por: Díaz-Álvarez, Josefa, et al.
Publicado: (2022)

Tau Filaments and the Development of Positron Emission Tomography Tracers
por: Goedert, Michel, et al.
Publicado: (2018)

Editorial: Translational imaging in neurodegenerative proteinopathies
por: Ni, Ruiqing, et al.
Publicado: (2022)

Positron Emission Computed Tomography Imaging of Synaptic Vesicle Glycoprotein 2A in Alzheimer’s Disease
por: Kong, Yanyan, et al.
Publicado: (2021)

Amyloid and Tau Positron Emission Tomography Imaging in Alzheimer’s Disease and Other Tauopathies
por: Maschio, Cinzia, et al.
Publicado: (2022)

Positron emission tomography imaging of dementia
por: Small, Gary W.
Publicado: (2000)

Positron Emission Tomography in Animal Models of Tauopathies
por: Cao, Lei, et al.
Publicado: (2022)

A Multi-Atlas-Based [18F]9-Fluoropropyl-(+)-Dihydrotetrabenazine Positron Emission Tomography Image Segmentation Method for Parkinson’s Disease Quantification
por: Pan, Yiwei, et al.
Publicado: (2022)

Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity
por: Chun, Min Young, et al.
Publicado: (2023)

Regional Associations of Cortical Superficial Siderosis and β-Amyloid-Positron-Emission-Tomography Positivity in Patients With Cerebral Amyloid Angiopathy
por: Finze, Anika, et al.
Publicado: (2022)

Effect of cognitive reserve on amnestic mild cognitive impairment due to Alzheimer’s disease defined by fluorodeoxyglucose-positron emission tomography
por: Kato, Takashi, et al.
Publicado: (2022)

Novel Positron Emission Tomography Tracers for Imaging Vascular Inflammation
por: Ćorović, Andrej, et al.
Publicado: (2020)

Photo-Oxygenation as a New Therapeutic Strategy for Neurodegenerative Proteinopathies by Enhancing the Clearance of Amyloid Proteins
por: Tomizawa, Ikumi, et al.
Publicado: (2022)

Tracers progress for positron emission tomography imaging of glial-related disease
por: Jia, Haoran, et al.
Publicado: (2022)

Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose
por: Zhu, Jing, et al.
Publicado: (2022)

Development of the First Potential Nonpeptidic Positron Emission Tomography Tracer for the Imaging of CCR2 Receptors
por: Wagner, Stefan, et al.
Publicado: (2020)

Imaging of Reactive Astrogliosis by Positron Emission Tomography
por: Harada, Ryuichi, et al.
Publicado: (2022)

Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies
por: Perani, Daniela, et al.
Publicado: (2019)

First-in-class positron emission tomography tracer for the glucagon receptor
por: Velikyan, Irina, et al.
Publicado: (2019)

Develop a diagnostic tool for dementia using machine learning and non-imaging features
por: Wang, Huan, et al.
Publicado: (2022)

Positron Emission Tomography in Animal Models of Alzheimer’s Disease Amyloidosis: Translational Implications
por: Ni, Ruiqing
Publicado: (2021)

Development and Clinical Application of Positron Emission Tomography Imaging Agents for Monoamine Oxidase B
por: Meyer, Jeffrey H., et al.
Publicado: (2022)

Editorial: Biomarkers from multi-tracer and multi-modal neuroimaging in age-related neurodegenerative diseases
por: Nie, Binbin
Publicado: (2022)

Compelling Case for Fostering Titanium-45 for Positron Emission Tomography Tracer Applications
por: Ramamoorthy, Natesan
Publicado: (2020)

Contribution of Different Positron Emission Tomography Tracers in Glioma Management: Focus on Glioblastoma
por: Moreau, Aurélie, et al.
Publicado: (2019)

Carbon-11 and Fluorine-18 Labeled Amino Acid Tracers for Positron Emission Tomography Imaging of Tumors
por: Sun, Aixia, et al.
Publicado: (2018)

Biodistribution and radiation dosimetry of multiple tracers on total-body positron emission tomography/computed tomography
por: Li, Lianghua, et al.
Publicado: (2023)

The Development of Positron Emission Tomography Tracers for In Vivo Targeting the Kinase Domain of the Epidermal Growth Factor Receptor
por: Högnäsbacka, Antonia, et al.
Publicado: (2022)

(18)F-THK5351 Positron Emission Tomography Imaging in Neurodegenerative Tauopathies
por: Ezura, Michinori, et al.
Publicado: (2021)

Development of a blood sample detector for multi-tracer positron emission tomography using gamma spectroscopy
por: Velasco, Carlos, et al.
Publicado: (2019)

Development of a New Positron Emission Tomography Tracer for Targeting Tumor Angiogenesis: Synthesis, Small Animal Imaging, and Radiation Dosimetry
por: Patterson, Cam, et al.
Publicado: (2013)

Statistical Parametric Mapping in Amyloid Positron Emission Tomography
por: Smith, Natasha M., et al.
Publicado: (2022)

Autoradiography screening of potential positron emission tomography tracers for asymptomatic abdominal aortic aneurysms
por: Tegler, Gustaf, et al.
Publicado: (2014)

Discordant findings of different positron emission tomography/CT tracers in a case of glioblastoma
por: Kumar, Ram Elumalai, et al.
Publicado: (2021)

Brain Molecular Connectivity in Neurodegenerative Diseases: Recent Advances and New Perspectives Using Positron Emission Tomography
por: Sala, Arianna, et al.
Publicado: (2019)

Dual-tracer positron emission tomography/computed tomography as an imaging probe of de novo lipogenesis in preclinical models of hepatocellular carcinoma
por: Tsao, Chin-Ho, et al.
Publicado: (2022)

Structural MRI Reveals Cervical Spinal Cord Atrophy in the P301L Mouse Model of Tauopathy: Gender and Transgene-Dosing Effects
por: Sartoretti, Thomas, et al.
Publicado: (2022)

Contributions of blood–brain barrier imaging to neurovascular unit pathophysiology of Alzheimer’s disease and related dementias
por: Uchida, Yuto, et al.
Publicado: (2023)

Biological principles and clinical application of positron emission tomography-tracers in prostate cancer: a review
por: Machado Rocha, José M., et al.
Publicado: (2019)

Multimodal magnetic resonance imaging on brain structure and function changes in vascular cognitive impairment without dementia
por: Zhang, Qinhong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6386fn9iib89orvjfroenmj1mq